BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30
• 31

• Pharm Country

  Palatin Technologies Completes $20 Million Equity And $10 Million Debt Financings

  December 24, 2014

   · 

  6 min read
• Drug Development

  Kinex Pharmaceuticals Announces First Patient Dosed With KX2-361 In A Phase 1 Clinical Study

  December 24, 2014

   · 

  3 min read
• Business

  Matthew O’Brien Joins Piper Jaffray Medical Technology Investment Research Team

  December 24, 2014

   · 

  1 min read
• Business

  Alcyone Lifesciences Appoints Michael Rogawski, International Expert In Treatment Of Seizures And Epilepsy To Its Clinical And Scientific Advisory Board

  December 24, 2014

   · 

  1 min read
• Business

  Biogen Idec To Report Fourth Quarter And Year End 2014 Financial Results On January 28, 2015

  December 24, 2014

   · 

  1 min read
• Business

  CEL-SCI Reports Fiscal 2014 Financial Results And Clinical & Corporate Developments

  December 24, 2014

   · 

  1 min read
• Drug Development

  Biocryst Pharmaceuticals Receives Orphan Drug Designation For BCX4161 For The Treatment Of Hereditary Angioedema

  December 24, 2014

   · 

  4 min read
• Deals

  Bellicum Pharmaceuticals, Inc. Announces Closing Of Initial Public Offering And Exercise Of The Underwriters’ Option

  December 24, 2014

   · 

  1 min read
• Deals

  Juno Therapeutics Announces Closing Of Initial Public Offering, Including Full Exercise Of Underwriters’ Option To Purchase Additional Shares

  December 24, 2014

   · 

  1 min read
• Business

  BioLineRx Ltd. Out-Licenses Novel Skin Lesion Treatment To Omega Pharma

  December 24, 2014

   · 

  1 min read